# Dad's Weekly Health Review — 05 Oct – 11 Oct 2026
Subject: Robert Herbert-Blankson (92), UK. Right BKA (2024), prostate cancer survivor (prostatectomy), peripheral vascular disease, dilated vessel (aneurysm surveillance), wheelchair-bound, diabetes, CKD.

## 🔴 Red Flags
- **Cadence still fractured (dominant risk).** Only ONE wellbeing check-in archived in-window: 10 Oct (`DAD_WELLBEING_2026-10-10.md`), which itself flags a 9-day gap since 01 Oct = 3 missed cycles. On the 3-day cadence (10:00 every 3 days), runs due 04 + 07 Oct have no archived file → 2 missed cycles fall inside this window.
- **Care-team confirmation items remain all-unchecked** and re-listed across consecutive check-ins: record next PSA date/result, confirm dilated-vessel (AAA) scan interval + BP target, resolve compression-stocking/skin/cushion review, capture 16/07/26 Diabetic Foot Day Case outcome (now ~12 weeks unrecorded).

## 🟡 Watch
- **Connectivity infra fragile:** farm-weekly-review still reports `httpx.ConnectError: getaddrinfo failed` — the same failure class that blocked dad's 3-day loop last cycle. Dad jobs now show `last_delivery_error = None`, but the underlying network remains intermittently down; monitor.
- **No confirmed vitals this window:** no PSA result, BP reading, skin-check report, or DAPT-adherence confirmation to trend.
- **Active-condition tracking gap persists:** prostate-cancer survivorship + dilated-vessel/aneurysm surveillance still absent from master `FAMILY_INSIGHTS_DAD.md` (last updated 19 May 26).

## 🟢 Good
- **Delivery channel cleared on both dad jobs** — 3-day loop `5f6fafe0aba8` and weekly `16c8a6f32eb5` both report `last_delivery_error = None` (previously ConnectError).
- 10 Oct check-in freshly researched and current (2026 prostate survivorship, NICE NG156 AAA, VA/DoD amputation rehab, NICE NG89).
- No acute red flags in-window: no fall, no acute stump/foot issue, no acute wound reported.

## 📈 Trends
- Advisory content stable, well-targeted, current (survivorship + frailty-appropriate surveillance; AAA interval + BP; DVT/hydration + repositioning; stump/contralateral skin; pressure relief; uninterrupted DAPT).
- Persistent pattern: confirmation-type action items are re-listed, never closed — no confirmatory data (PSA, BP, scan date, skin check) enters the logs.
- Monitoring reliability is improving on the delivery side but the archive cadence still lags (1 file in 7 days vs 2–3 expected).

## 💡 Recommendations
1. **Verify the 3-day loop RUNS (not just delivers):** delivery channel is now clear, so confirm the 04/07 Oct runs actually executed and archived; next due 13 Oct must land a file.
2. **Chase confirmed clinical data with GP/vascular:** (a) record the next PSA + last result — at 92 with significant comorbidities, annual PSA adjusted by frailty is appropriate (newer evidence: more frequent testing adds procedures but not survival); do NOT silently stop; (b) confirm aneurysm scan interval + BP target; (c) get the 16/07 Diabetic Foot outcome (~12 weeks late).
3. **Keep DVT guardrail PAD-safe:** compression stockings and IPC remain contraindicated with peripheral arterial disease (NICE NG89 + vascular surgery guidance). Rely on hydration, hourly repositioning, pressure-redistributing cushion, daily skin checks (reddening subtle on darker skin), and UNINTERRUPTED DAPT (aspirin + clopidogrel) — confirm adherence with the Southwark 4x-visit care team.

— ONE lever today: **confirm DAPT adherence + hourly repositioning with the care team, and get the next PSA date recorded** — prostate survivorship in a 92-year-old with PVD is best guarded by uninterrupted antiplatelet cover and frailty-adjusted, not abandoned, annual PSA surveillance.
— Sources: DAD_WELLBEING_2026-10-10.md (memories/family/dad); DAD_WEEKLY_REVIEW_2026-10-04.md; FAMILY_INSIGHTS_DAD.md (vault, updated 19 May 26); cron jobs.json — weekly `16c8a6f32eb5` + 3-day `5f6fafe0aba8` both last_delivery_error=None; farm-weekly-review still getaddrinfo-failing. Live web: VA/DoD Lower Limb Amputation CPG (2025); AFT-30/NCI (PSA surveillance intensity vs survival); NICE NG89 + vascular-surgery volume (AES/IPC contraindicated in PAD).